9 min listen
Shankar Siva on radiotherapy for primary renal cell carcinoma
Shankar Siva on radiotherapy for primary renal cell carcinoma
ratings:
Length:
9 minutes
Released:
Nov 28, 2022
Format:
Podcast episode
Description
Shankar Siva (Peter MacCallum Cancer Centre, Melbourne, Australia) discusses his Article on 5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinoma.Read the full article:5-year outcomes after stereotactic ablative body radiotherapy for primary renal cell carcinomaContinue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
Released:
Nov 28, 2022
Format:
Podcast episode
Titles in the series (100)
The Lancet Oncology: June 30, 2008 by The Lancet Oncology in conversation with